Vasopressin during uncontrolled hemorrhagic shock: Less bleeding below the diaphragm, more perfusion above

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 830-832

  Stadlbauer, Karl H ^a,b   Wenzel, Volker ^a   Krismer, Anette C ^a   Voelckel, Wolfgang G ^a   Lindner, Karl H ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN;

ARTERIAL PRESSURE; BLEEDING; CLINICAL TRIAL; COLLOID; CRYSTALLOID; DIAPHRAGM; EDITORIAL; FIRST AID; HEART ARREST; HEART MUSCLE ISCHEMIA; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; INJURY; MORBIDITY; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RESUSCITATION; SHOCK; SURVIVAL;

EID: 23944514833     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000175217.55775.1C     Document Type: Editorial

References (27)

1. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004;350:105-13.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
3. Deakin CD, Hicks IR. AB or ABC: pre-hospital fluid management in major trauma. J Accid Emerg Med 1994;11:154-7.
4. Rosemurgy AS, Norris PA, Olson SM, et al. Prehospital traumatic cardiac arrest: the cost of futility. J Trauma 1993;35: 468-73.
5. Shoemaker WC, Peitzman AB, Bellamy R, et al. Resuscitation from severe hemorrhage. Crit Care Med 1996;24:S12-23.
6. Heckbert SR, Vedder NB, Hoffman W, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998;45:545-9.
7. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-9.
8. Roberts I, Evans P, Bunn F, et al. Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet 2001;357: 385-7.
9. Kwan I, Bunn F, Roberts I, on behalf of the WHO Pre-Hospital Trauma Care Steering Committee. Timing and volume of fluid administration for patients with bleeding. Cochrane Database of Systematic Reviews 2003;3:CD002245.
10. Voelckel WG, Raedler C, Wenzel V, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med 2003;31: 1160-5.
11. Stadlbauer KH, Wagner-Berger HG, Raedler C, et al. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 2003;98:699-704.
12. Shelly MP, Greatorex R, Calne RY, Park GR. The physiological effects of vasopressin when used to control intra-abdominal bleeding. Intensive Care Med 1988;14:526-31.
13. Krismer AC, Wenzel V, Voelckel WG, et al. Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock: three cases and a brief analysis of the literature [in German] Anaesthesist 2005;54:220-4.
14. Haas T, Voelckel WG, Wiedermann F, et al. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J Trauma 2004;57:177-9.
15. Kleemann PP, Jantzen JP, Dick W. Undesirable effects following the local injection of ornipressin during general anesthesia: can the risk be lessened? A prospective study [in German] Anaesthesist 1988;37:551-7.
16. Yeh CC, Wu CT, Lu CH, et al. Early use of small-dose vasopressin for unstable hemodynamics in an acute brain injury patient refractory to catecholamine treatment: a case report. Anesth Analg 2003;97:577-9.
17. Wenzel V. Infusing arginine vasopressin: raising red flags versus the effects of the underlying physiology. Pharmacol Res 2002;46:371-3.
18. Dunser MW, Mayr AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001;93:7-13.
19. Dunser M, Wenzel V, Mayr AJ, Hasibeder WR. Arginine vasopressin in vasodilatory shock: a new therapy approach? [in German] Anaesthesist 2002;51:650-9.
20. Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 2003;63:237-56.
21. Sharma RM, Setlur R. Vasopressin in hemorrhagic shock. Anesth Analg 2005;101:833-4.
22. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999;100:226-9.
23. Fox AW, May RE, Mitch WE. Comparison of peptide and non-peptide receptor-mediated responses in rat tail artery. J Cardiovasc Pharmacol 1992;20:282-9.
24. Mayr VD, Wenzel V, Voelckel WG, et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001;104:1651-6.
25. Lindner KH, Prengel AW, Brinkmann A, et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996;124:1061-4.
26. Tsuneyoshi I, Onomoto M, Yonetani A, et al. Low-dose vasopressin infusion in patients with severe vasodilatory hypotension after prolonged hemorrhage during general anesthesia. J Anesth 2005;19:170-3.
27. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg 2004;98:1759-66.